SCHEMBL4596824

SCHEMBL4596824

CC1(C)NC(=O)N([C@H](Cc2ccccc2)C(=O)O)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
PKM P14618 1/20 0.56
GAA P10253 1/20 0.56
KMT2A Q03164 3/20 0.51
AADAT Q8N5Z0 1/20 0.51
POLB P06746 5/20 0.50
MAPT P10636 4/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
HSD17B10 Q99714 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTPN7 P35236 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
NPSR1 Q6W5P4 1/20 0.49
TSHR P16473 1/20 0.47
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4596553 1.00 ALDH1A1 (0.56) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4596548 1.00 ALDH1A1 (0.56) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4597348 0.83 ALDH1A1 (0.57) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4596955 0.83 ALDH1A1 (0.57) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4595682 0.82 ALDH1A1 (0.56) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4596801 0.82 ALDH1A1 (0.56) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4597279 0.80 ALDH1A1 (0.52) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4596916 0.80 ALDH1A1 (0.52) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4596920 0.80 ALDH1A1 (0.52) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4596864 0.76 KMT2A (0.44) GAAKMT2APOLBL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506177-B1 PROCESS FOR THE PREPARATION OF THE ENANTIOMERIC FORMS OF 2-SUBSTITUTED 2-(2,5-DIOXOIMIDAZOLIDIN-1-YL)-ACETIC ACID DERIVATIVES SANOFI AVENTIS DEUTSCHLAND (DE) 2008-01-16 EP disclosed
US-6908752-B2 Process for the preparation of the enant iomeric forms of 2-substituted 2- (2, 5-dioxoimidazolidin-1yl) -acetic acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-06-21 US disclosed
US-20030054507-A1 Process for the preparation of the enant iomeric forms of 2-substituted 2- (2, 5-dioxoimidazolidin-1-yl) -acetic acid derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2003-03-20 US disclosed